Corpus overview


Overview

MeSH Disease

Human Phenotype

Transmission

Seroprevalence

There are no seroprevalence terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page




    Impact of the Novel Coronavirus Disease MESHD (COVID-19) on Treatment Adherence and Sleep Duration in Obstructive Sleep Apnea HP Obstructive Sleep Apnea MESHD Patients Treated with Positive Airway Pressure

    Authors: Salma Batool-Anwar; Olabimpe S Omobomi; Stuart F Quan

    doi:10.1101/2020.06.28.20141994 Date: 2020-06-29 Source: medRxiv

    Objective To examine the effect of COVID-19 on treatment adherence and self-reported sleep duration among patients with Obstructive Sleep Apnea HP Obstructive Sleep Apnea MESHD ( OSA MESHD) treated with positive airway pressure (PAP) therapy. Methods Retrospective review of medical records of patients seen in Sleep and Circadian Clinic at Brigham Health during the immediate period of one month after the national lockdown was announced on March 15, 2020. Patients with OSA MESHD were included only if PAP adherence data was available in the 12- months prior and in the month after the lockdown. Patients with other sleep disorders MESHD and OSA MESHD patients without the adherence data were excluded. Results Mean age TRANS was 63.5 +/- 13.9 years, 55% of the participants were men, and mean BMI was 31.8 +/- 7.9 kg/m2. Severe OSA MESHD was noted among 59.5% compared to 29.3% moderate, and 11.2% mild OSA MESHD. Increased number of patients reported insomnia HP insomnia MESHD after the lockdown (41% vs 48%, p= 0.02). Gender TRANS stratification noted worsening insomnia HP insomnia MESHD only among women. There was no significant difference in PAP adherence as measured by the hours of use, self-reported sleep duration or in the use of sleep medications. Conclusion Post COVID-19 lockdown had a negative impact on sleep as evidenced by increased reporting of insomnia HP insomnia MESHD particularly among women, but no impact on PAP adherence or self-reported sleep duration.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from Preprints.org and is updated on a daily basis (7am CET/CEST).
The web page can also be accessed via API.

Sources


Annotations

All
None
MeSH Disease
Human Phenotype
Transmission
Seroprevalence


Export subcorpus as...

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.